Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea

Medical Termination of Pregnancy Clinical Trial

Official title:
Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea

Status Completed

Clinical Trial Summary

This study is a non-interventional prospective, multicenter, longitudinal study conducted in France, among a representative sample of public and/or private birth control centers.

The aim of the study is to assess, in real-life settings, the success rate of the protocol Mifegyne / prostaglandin analogue in patients asking for medical abortion either prior or beyond 7 weeks of amenorrhea.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02614781
Study type	Observational
Source	Nordic Pharma SAS
Contact
Status	Completed
Phase	N/A
Start date	November 2015
Completion date	May 2016

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02171845` - Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans
	Recruiting	`NCT04294212` - Medical Termination of Pregnancy : Evaluation of Patients' Practices and Feelings in Brest Hospital
	Completed	`NCT05202639` - Decision-making Regarding the Possibility of Medical Termination of Pregnancy